EphyX in the TOP10 CROs in Europe

Updated: Jan 25, 2020

EphyX Neuroscience has been recognized as one of the TOP10 CROs in Europe by PharmaTech Outlook for the innovative solutions it offers and their impact on the pharmaceutical industy.

The selection process for the Top 10 CROs involved a distinguished panel of CEOs, CIOs, VCs and analysts along with the Pharma Tech Outlook editorial panel to identify the leading CROs using key metrics including technology platforms and impact on the industry.

EphyX was selected particularly because of its routine use of iPSC-derived human neuronal cultures that provides more reliable and predictive data than the usual rodent tissues used in preclinical CNS-related studies. Find the complete article here